PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.77%
Revenue growth of 3.77% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
2.33%
Gross profit growth of 2.33% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
7.47%
EBIT growth of 7.47% while Healthcare median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
11.60%
Operating income growth of 11.60% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand.
7.06%
Net income growth of 7.06% while Healthcare median is zero. Walter Schloss might see potential if moderate gains can keep rising.
7.10%
EPS growth of 7.10% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
7.10%
Diluted EPS growth of 7.10% while Healthcare median is zero. Walter Schloss might see a slight edge that could improve over time.
0.00%
Share change of 0.00% while Healthcare median is zero. Walter Schloss would see if the modest difference matters long-term.
0.00%
Diluted share change of 0.00% while Healthcare median is zero. Walter Schloss might see a slight difference in equity issuance policy.
No Data
No Data available this quarter, please select a different quarter.
-113.60%
Negative OCF growth while Healthcare median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-470.38%
Negative FCF growth while Healthcare median is 0.00%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
30.78%
10Y CAGR of 30.78% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
30.78%
5Y CAGR of 30.78% while Healthcare is zero. Walter Schloss might see a slight improvement that could compound if momentum builds.
30.78%
3Y CAGR of 30.78% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
73.51%
OCF/share CAGR of 73.51% while Healthcare median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
73.51%
5Y OCF/share growth exceeding 1.5x Healthcare median of 12.77%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
73.51%
3Y OCF/share growth > 1.5x Healthcare median of 5.49%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
96.43%
Net income/share CAGR exceeding 1.5x Healthcare median of 45.07% over a decade. Joel Greenblatt might see a standout compounder of earnings.
96.43%
5Y net income/share CAGR > 1.5x Healthcare median of 39.81%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
96.43%
3Y net income/share CAGR > 1.5x Healthcare median of 26.71%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
48.59%
Equity/share CAGR of 48.59% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
48.59%
5Y equity/share CAGR of 48.59% while Healthcare median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
48.59%
3Y equity/share CAGR of 48.59% while Healthcare median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.84%
Decreasing inventory while Healthcare is rising. Seth Klarman might see an efficiency advantage or possibly a sign of weaker sales future.
-1.83%
Assets shrink while Healthcare median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
4.96%
BV/share growth of 4.96% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
-10.36%
Debt is shrinking while Healthcare median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.